Branded Products for Medical Device Companies: Why the Central Warehouse Model is Costing You More Than You Think

TL;DR: Many medical device companies still manage branded products, marketing materials, sales collateral, and trade show assets through a central warehouse model. While this approach provides control, it often creates high shipping costs, long lead times, customs delays, excess inventory, and waste as organisations expand internationally. Local, on-demand production offers an alternative by allowing approved marketing materials and promotional products to be produced closer to where they are needed, helping global medical device companies reduce logistics costs, improve responsiveness, maintain brand consistency, and better support subsidiaries, distributors, and trade show teams worldwide.

Medical device companies are good at precision. Tolerances are measured in microns. Regulatory submissions run to thousands of pages. Quality systems are audited, documented, and re-audited.

Then there is the branded products process.

Brochures designed at HQ in Germany, printed in bulk, warehoused in a distribution centre in the Netherlands, and shipped to sales teams in Australia, Latin America, and the US. Promotional products ordered centrally, months in advance, to arrive in time for trade shows that sometimes reschedule. Business cards approved by head office and waiting six weeks to land on a desk in Singapore.

It is not broken. It just was not built for the scale of international expansion most medical device companies are now navigating.

For organisations operating across multiple countries, managing branded products, marketing materials, sales collateral, and trade show assets has become a growing logistical challenge.

The Problem Is Structural, Not Operational

When a medical device company opens a new subsidiary, the marketing question is usually: how do we get them branded materials?

The answer, almost universally, is the same one that worked for the first subsidiary. Produce centrally. Ship outward. Repeat.

That model carries hidden costs that compound as the organisation grows. Shipping a pallet of brochures, exhibition materials, or promotional items from Frankfurt to Auckland is not just expensive. It takes weeks. It generates emissions. And if the event is cancelled, the product goes into storage or into a skip.

For companies with 12 or 15 subsidiaries across multiple continents, this is not a one-off inefficiency. It is a structural cost built into every campaign, product launch, conference, trade show appearance, and sales enablement programme.

The marketing team in one respiratory device company described the situation directly: they produce promotional products and marketing collateral in Germany and ship globally, including to Australia, the US, and Latin America. Shipping time and cost are the biggest pain points. And when a local team requests branded materials for a trade show two weeks out, the answer is usually no.

That is not a failure of planning. That is a model working exactly as designed, and the design no longer fits.

What Changes After Acquisition

Medical device companies grow. And they frequently grow through acquisition.

Each acquisition brings a new subsidiary, a new country, a new local marketing team, often one with four or five people managing the entire branded collateral workflow for that market. They need business cards, brochures, exhibition materials, promotional products, and sales collateral. They do not have the headcount to manage local supplier relationships. They rely on whatever comes from HQ.

Post-COVID, many companies ramped up their international presence again after years of operational contraction. The number of markets they need to serve is increasing. The central model that handled eight countries is now trying to serve eighteen.

At the same time, the mix of who needs branded materials has changed. It is not just employees. Distributors, clinical training partners, and external sales agents need business cards, brochures, catalogues, and marketing materials that carry the brand correctly. Payment needs to work for external users, often via credit card. That is a different workflow from a straightforward internal ordering system.

The Trade Show Problem

Trade shows are non-negotiable for medical device companies. Medica, World Health Expo (formerly Arab Health), Compamed, RSNA: the calendar is full and the lead times are short.

The central model requires advance planning. Print runs are large. Lead times account for production, warehousing, and international freight. If a company commits to a stand in a new market with six weeks to go, the standard model struggles.

Local teams know this. They have absorbed the delays. They have learned to request items far earlier than they need them, because the system requires it. But does the system need to work this way?

It does not.

On-demand local production means a team in Madrid, Seoul, or Chicago can order branded materials, trade show materials, brochures, promotional products, and sales collateral and have them produced by a verified local supplier, in the correct language, with approved assets, and delivered in days. No freight coordination. No customs documentation. No warehouse holding stock that may never be used.

The Hidden Cost of International Shipping

International shipping introduces transportation costs – but not only.

Marketing materials and promotional products crossing borders are subject to customs procedures, import duties, local documentation requirements, and delivery delays. While brochures and promotional items are far less regulated than medical devices themselves, they still inherit the complexity of international logistics.

For global marketing teams, that complexity translates into additional administration, reduced flexibility, and longer lead times whenever branded materials are needed in a local market.

The Business Case Question

Every marketing manager at a medical device company who has evaluated a platform like Ciloo has said some version of the same thing: the technology makes sense. The challenge is making the numbers work for the decision maker.

That business case is, in fact, easier to make than it appears. The question is not whether on-demand local production is more convenient, it’s what the current model actually costs.

Shipping costs from a central warehouse to a network of subsidiaries across multiple continents add up. So does storage. So does waste: product that was printed in bulk for a campaign that changed, or stock that has been sitting in a facility in the Netherlands since the brand refresh eighteen months ago. So does the internal time spent coordinating orders, chasing suppliers, and managing logistics across time zones.

A company with 50,000 to 100,000 euros in annual print and promotional product spend for one market alone, and significantly more when international subsidiaries are included, has a number worth stress-testing against a structural alternative.

Global Consistency Is the Starting Point, Not the Constraint

One assumption worth examining is that central production is necessary for brand control.

In practice, the medical device marketing teams in these conversations do not report brand consistency as their primary concern. Local teams generally adhere to brand standards. The challenge is not rogue marketing. It is slow, expensive, and inflexible logistics.

A platform that holds approved assets, locked templates, and pre-approved product ranges gives local teams exactly as much flexibility as the central marketing function decides to allow, and no more. Brand control and local ordering are not competing objectives. They are the same system, configured correctly.

The phrase that captures this is simple: global consistency, local execution. The brand is defined once. The materials are produced where they are needed, when they are needed.

What Branded Products for Medical Device Companies Actually Look Like

The use cases are consistent across the sector.

• Business cards for employees and distributors.

• Marketing collateral such as brochures, catalogues, product sheets, and clinical education materials.

• Trade show materials and exhibition assets for conferences and events.

• Promotional products such as pens, tote bags, drinkware, umbrellas, and giveaways for customer engagement activities.

These items are all operational requirements. And because they are operational rather than strategic, they tend to be managed in the least efficient way available: ad hoc requests, fragmented suppliers, bulk orders that arrive too late or in quantities nobody wanted.

A structured approach makes it easier to get these products right, at lower cost, in more markets, and without the coordination overhead that currently sits on the marketing team’s plate.

The Right Question to Ask

If your branded products, marketing materials, or sales collateral are currently produced in one or two locations and shipped to your markets globally, the question to ask is what would it take to produce those same materials closer to where they are used.

How many countries do you serve? How many billing entities? How many of your markets have local teams who order from a central warehouse because that is the only option available to them?

That is the scope of the problem. The solution is a platform built specifically for organisations managing branded products, marketing collateral, and promotional products across a global network, where the cost of the current model is hiding in logistics budgets, warehouse contracts, and the time local teams spend waiting.

Ciloo is a global branded products platform for multinational organisations. It connects central brand teams with local on-demand production, so the right materials reach the right people, produced in-country, without the freight. 

If your marketing materials are still being produced centrally and shipped globally, it may be time to quantify what that model is really costing.

Book a demo to explore how local, on-demand production can reduce logistics costs, shorten lead times, and simplify branded product management across every market.

Frequently Asked Questions